Differential expression of cathepsin X in aging and pathological central nervous system of mice
- PMID: 17306794
- DOI: 10.1016/j.expneurol.2007.01.007
Differential expression of cathepsin X in aging and pathological central nervous system of mice
Abstract
Increasing evidence of a fundamental influence of cathepsins on inflammation has drawn interest in a thorough understanding of their role in physiological and pathological processes. Even though the number of identified cathepsins has more than doubled in the last years, information about their expression, regulation and function in the brain is still incomplete. In the present study we analyzed the regional, cellular and subcellular localization and the activity of the recently discovered cathepsin X in the normal, developing and pathological mouse brain. Our results show that CATX is: (i) is expressed in almost all cells in the mouse brain with a preference for glial cells; (ii) already widely expressed early in development and age-dependently upregulated in amount and activity; (iii) prominently localized in the lysosomal system but also scattered in the somal cytoplasm in the aged brain; (iv) upregulated in numerous glial cells of degenerating brain regions in a transgenic mouse model of amyotrophic lateral sclerosis; and (v) associated with plaques in a transgenic mouse model and in Alzheimer patients. These results strongly suggest that cathepsin X is an important player in degenerative processes during normal aging and in pathological conditions.
Similar articles
-
Upregulation of cathepsin S in the aging and pathological nervous system of mice.Brain Res. 2008 Sep 26;1232:7-20. doi: 10.1016/j.brainres.2008.07.067. Epub 2008 Jul 29. Brain Res. 2008. PMID: 18694734
-
An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.Neuroscience. 2012 Jul 26;215:160-73. doi: 10.1016/j.neuroscience.2012.04.043. Epub 2012 Apr 25. Neuroscience. 2012. PMID: 22542680
-
Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1.Brain Res. 2007 Jul 30;1160:1-10. doi: 10.1016/j.brainres.2007.05.044. Epub 2007 Jun 4. Brain Res. 2007. PMID: 17583678
-
Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.J Comp Neurol. 2007 Jan 1;500(1):20-46. doi: 10.1002/cne.21160. J Comp Neurol. 2007. PMID: 17099894
-
Familial amyotrophic lateral sclerosis and Alzheimer's disease. Transgenic models.Adv Exp Med Biol. 1998;446:145-59. Adv Exp Med Biol. 1998. PMID: 10079842 Review. No abstract available.
Cited by
-
Cysteine cathepsins in neurological disorders.Mol Neurobiol. 2014 Apr;49(2):1017-30. doi: 10.1007/s12035-013-8576-6. Epub 2013 Nov 15. Mol Neurobiol. 2014. PMID: 24234234 Review.
-
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.Nat Neurosci. 2014 Jan;17(1):121-30. doi: 10.1038/nn.3588. Epub 2013 Nov 24. Nat Neurosci. 2014. PMID: 24270187 Free PMC article.
-
Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells.Front Cell Neurosci. 2014 Aug 7;8:214. doi: 10.3389/fncel.2014.00214. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25147500 Free PMC article.
-
Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo.Front Mol Neurosci. 2020 Nov 20;13:575453. doi: 10.3389/fnmol.2020.575453. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33328882 Free PMC article.
-
Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease.Front Mol Neurosci. 2018 Nov 2;11:412. doi: 10.3389/fnmol.2018.00412. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30450037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical